TRGNF: Transgene SA Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 209.78
Enterprise Value ($M) n/a
Book Value ($M) 15.20
Book Value / Share 0.12
Price / Book n/a
NCAV ($M) -6.30
NCAV / Share -0.05
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) -1.33
Return on Assets (ROA) -0.67
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 1.48
Current Ratio 1.48

Balance Sheet (mrq) ($M)
Current Assets 20.67
Assets 42.17
Liabilities 26.97
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 6.35
Operating Income -35.66
Net Income -33.97

Cash Flow Statement (mra) ($M)
Cash From Operations -23.55
Cash from Investing -3.21
Cash from Financing 26.96

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

Similar Companies
TNGNQ – Tengion, Inc. TQLB – Torque Lifestyle Brands, Inc.
TRGM – Targeted Medical Pharma, Inc. TRVN – Trevena, Inc.
TSMRF – Tsumura & Co.


Financial data and stock pages provided by
Fintel.io